🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

6+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 6 recruiting trials for “Small cell carcinoma of the bladder”

Phase 1Enrolling by InvitationNCT07218003 ↗

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

👨‍⚕️ Thomas Manley, MD, Rondo Therapeutics📍 7 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06161532 ↗

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

👨‍⚕️ Andrea B Apolo, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06228066 ↗

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

👨‍⚕️ Andrea B Apolo, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT06257264 ↗

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

👨‍⚕️ Study Director, BeiGene📍 24 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05312671 ↗

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

👨‍⚕️ Jean Hoffman-Censits, MD, Johns Hopkins University📍 2 sites📅 Started Jun 2022View details ↗
RecruitingNCT05621837 ↗

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

👨‍⚕️ Licia Rivoltini, Fondazione IRCCS Istituto Nazionale Tumori - Milan📍 1 site📅 Started Mar 2022View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →